Cargando…

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States

RESEARCH OBJECTIVE: Medication opioid use disorder (MOUD) treatment is the first-line approach to the treatment of opioid use disorder (OUD). This analysis seeks to identify “critical access” MOUD facilities that ensure geographic access for MOUD patients. Using public-source data and spatial analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollack, Harold A., Lee, Francis, Paykin, Susan, Aguilera, Javier Andres Rojas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040320/ https://www.ncbi.nlm.nih.gov/pubmed/36994373 http://dx.doi.org/10.1016/j.dadr.2022.100130

Ejemplares similares

Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD)
por: Mills, Rosalina, et al.
Publicado: (2022)

Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017
por: Khachikian, Tenie, et al.
Publicado: (2022)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
por: Russell, Cayley, et al.
Publicado: (2023)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder
por: Joudrey, Paul J., et al.
Publicado: (2022)

The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study
por: Livingston, Nicholas A., et al.
Publicado: (2022)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review
por: Banka-Cullen, Sonam Prakashini, et al.
Publicado: (2023)

Preferences, use, and perceived access to flavored e-cigarettes among United States adolescents and young adults
por: Chaffee, Benjamin W., et al.
Publicado: (2022)

Qualitative exploration of public health vending machines in young adults who misuse opioids: A promising strategy to increase naloxone access in a high risk underserved population
por: Wagner, Nicole M., et al.
Publicado: (2022)

What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
por: Keyes, Katherine M., et al.
Publicado: (2022)

Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program
por: Reed, Megan K., et al.
Publicado: (2023)

Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis
por: Eugenia Socias, M., et al.
Publicado: (2023)

Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid work
por: Bertz, Jeremiah W., et al.
Publicado: (2021)

Continuous facility location on graphs
por: Hartmann, Tim A., et al.
Publicado: (2021)

Reported firearm access among patients admitted to a dual diagnosis medically-assisted withdrawal unit over five years
por: Weleff, Jeremy, et al.
Publicado: (2022)

“You’re Not Supposed to be on it Forever”: Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids
por: Dickson-Gomez, Julia, et al.
Publicado: (2022)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model
por: Cloutier, Renee M., et al.
Publicado: (2023)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose
por: Sosnowski, David W., et al.
Publicado: (2022)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

Negative attitudes about medications for opioid use disorder among criminal legal staff
por: Moore, Kelly E., et al.
Publicado: (2022)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Dietary patterns of adolescent students during the COVID-19 pandemic lockdown
por: Martín-Rodríguez, Alexandra, et al.
Publicado: (2022)

Signal of increased opioid overdose during COVID-19 from emergency medical services data
por: Slavova, Svetla, et al.
Publicado: (2020)

Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Age-related changes in patients with upper limb thalidomide embryopathy in the United Kingdom
por: Markiewicz, Magdalena, et al.
Publicado: (2023)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
por: Durgin, Caitlyn J., et al.
Publicado: (2023)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8thcotunacrksljtf767k4n2op